ESLA earnings date and last-quarter result: next report 2026-09-02, last quarter beat, P/E -2.20. Updated 2026-07-23.
Estrella Immunopharma (ESLA) Research Hub
Estrella Immunopharma (ESLA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.9188 USD (-6.72%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.20, market cap 0.03B. This hub links to the full technical, earnings and options research available for ESLA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.9188 USD (-6.72%) |
| 52-week range | 0.24 USD – 1.15 USD |
| Trend regime | Range |
| 14-day RSI | 71.1 (Overbought) |
| Trailing P/E | -2.20 |
| Market cap | 0.03B |
| Dividend yield | 0.00% |
| Next earnings | 2026-09-02 |
Available research for ESLA
Covered Call on ESLA: how it works, illustrative setup around the real 0.9188 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ESLA: how it works, illustrative setup around the real 0.9188 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ESLA: how it works, illustrative setup around the real 0.9188 USD price, max profit/loss, breakeven and when to use it. Educational.
ESLA technical analysis: range, last 0.9188 USD, RSI 71.1, 52w range 0.24 USD–1.15 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ESLA in?
Estrella Immunopharma (ESLA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ESLA in an uptrend or downtrend?
As of 2026-10-26, ESLA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ESLA's trailing P/E ratio?
ESLA's trailing P/E is -2.20, with a market cap of 0.03B. See the earnings research page for full valuation detail.
When does ESLA next report earnings?
ESLA is next scheduled to report earnings on 2026-09-02.